Actively Recruiting
Canadian Pediatric Registry for Genetic Liver Cholestasis Including Alagille Syndrome and PFIC Subtypes
Led by Children's Hospital of Eastern Ontario · Updated on 2026-10-08
220
Participants Needed
13
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to build a national, multi-center registry in Canada for children under 18 with Alagille syndrome ALGS and Genetic Intrahepatic Cholestasis GIC, including various subtypes of Progressive Familial Intrahepatic Cholestasis PFIC. The registry seeks to collect standardized, high-quality data to better understand these rare genetic liver diseases, their clinical course, and treatment outcomes across pediatric hepatology centers nationwide. Participants include children diagnosed either retrospectively since January 1, 2022 or prospectively with ALGS or GIC, confirmed genetically or clinically. Data collection involves initial enrollment forms capturing demographics, genetics, clinical features, lab tests, imaging, and treatments. Retrospective participants provide annual follow-up data before transitioning to prospective 6-monthly visits, which include clinical reassessments, labs, imaging, and documentation of major clinical events. Throughout the study, participants are monitored until transition to adult care or study end. The registry tracks outcomes such as survival without liver transplantation or major liver events. Data management uses secure electronic systems ensuring confidentiality. This observational study does not involve interventions but focuses on long-term data collection to improve understanding of pediatric cholestatic liver diseases.
CONDITIONS
Brief Title
Pediatric Evaluation and Registry for Liver Cholestasis in Canada
Research Team
M
Mohit Kehar
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here